Reaction Details |
| Report a problem with these data |
Target | Interleukin-2 |
---|
Ligand | BDBM387281 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Inhibition of IL-2 secretion |
---|
IC50 | 550±n/a nM |
---|
Citation | Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK Oxazoline and isoxazoline derivatives as CRAC modulators US Patent US10292981 Publication Date 5/21/2019 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Interleukin-2 |
---|
Name: | Interleukin-2 |
Synonyms: | IL-2 | IL2 | IL2_HUMAN | INN=Aldesleukin | Interleukin-2 | Interleukin-2 (IL-2) | T-cell growth factor | TCGF |
Type: | Enzyme |
Mol. Mass.: | 17630.05 |
Organism: | Homo sapiens (Human) |
Description: | P60568 |
Residue: | 153 |
Sequence: | MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRML
TFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSE
TTFMCEYADETATIVEFLNRWITFCQSIISTLT
|
|
|
BDBM387281 |
---|
n/a |
---|
Name | BDBM387281 |
Synonyms: | N-(5-(5- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2- methylphenyl)pyridin- 2-yl)-2,6- difluorobenzamide | US10292981, Example 4 |
Type | Small organic molecule |
Emp. Form. | C24H19F2N3O3 |
Mol. Mass. | 435.4228 |
SMILES | Cc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)nc1)C1=NOC(C)(C)C1=O |t:27| |
Structure |
|